41 results
424B3
EVOK
Evoke Pharma Inc
14 Mar 24
Prospectus supplement
6:44pm
will require substantial additional funding and may be unable to raise capital when needed, which would force us to liquidate, dissolve or otherwise wind down … activities and may be required to liquidate, dissolve or otherwise wind down our operations. Any of these events could result in the complete loss
424B4
EVOK
Evoke Pharma Inc
9 Feb 24
Prospectus supplement with pricing info
5:14pm
capital when needed, which would force us to liquidate, dissolve or otherwise wind down our operations.
We have no internal sales, marketing … will require substantial additional funding and may be unable to raise capital when needed, which would force us to liquidate, dissolve or otherwise wind